Current studies have found that up-regulation of IL-33 in HCC leads to accelerated growth of HCC, and IL-33 may induce chemokines (such as Cxcl1) to enhance the recruitment of S100A9-secreting bone marrow cells to promote tumor progression (60). This evidence concerns the gene S100A9 and hepatocellular carcinoma.